Skip to content
10-Q

Quarterly Report

NU-MED PLUS, INC. NUMD

0001548123-24-000075

← back to feed
Filed
May 15, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 15, 2024 83.55M sh
Shares Diluted Q1 2024 · Mar 31, 2024 83.55M sh
Shares Diluted Q1 2024 · Mar 31, 2023 81.35M sh
Operating Cash Flow Q1 2024 · Mar 31, 2024 −$450
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$20.17K
Stockholders Equity Q1 2024 · Mar 31, 2024 −$168.58K
Stockholders Equity Q1 2024 · Dec 31, 2023 −$146.75K
Stockholders Equity Q1 2024 · Mar 31, 2023 −$91.23K
Stockholders Equity Q1 2024 · Dec 31, 2022 −$63.03K
Current Liabilities Q1 2024 · Mar 31, 2024 $177.59K
Current Liabilities Q1 2024 · Dec 31, 2023 $160.21K
Total Liabilities Q1 2024 · Mar 31, 2024 $177.59K
Total Liabilities Q1 2024 · Dec 31, 2023 $160.21K
Current Assets Q1 2024 · Mar 31, 2024 $9.02K
Current Assets Q1 2024 · Dec 31, 2023 $13.46K
Total Assets Q1 2024 · Mar 31, 2024 $9.02K
Total Assets Q1 2024 · Dec 31, 2023 $13.46K
Eps Diluted Q1 2024 · Mar 31, 2024 $0.00
Eps Diluted Q1 2024 · Mar 31, 2023 $0.00
Eps Basic Q1 2024 · Mar 31, 2024 $0.00
Eps Basic Q1 2024 · Mar 31, 2023 $0.00
Sga Expense Q1 2024 · Mar 31, 2024 $5.98K
Sga Expense Q1 2024 · Mar 31, 2023 $6.42K
Net Income Q1 2024 · Mar 31, 2024 −$21.83K
Net Income Q1 2024 · Mar 31, 2023 −$28.2K
Operating Income Q1 2024 · Mar 31, 2024 −$20.58K
Operating Income Q1 2024 · Mar 31, 2023 −$26.97K